MedTrace Logo

Efficacy and Safety of L Arginine to Prevent Preeclampsia

NCT02363348 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2016-03-04

No results posted yet for this study

Summary

Randomized double-blind controled clinical trial to assess the efficacy and safety of L-arginine to prevent preeclampsia.

applied to pregnant women with risk factors for preeclampsia. the main result was the development of preeclampsia as well as side effects to taking l arginine besides perinatal outcomes

Conditions

Interventions

DIETARY_SUPPLEMENT

L arginine

L arginine is a basic amino-acid precursor of nitric oxide main vasodilator.

OTHER

Placebo

calcined magnesia

Sponsors & Collaborators

  • Hospital Civil Juan I. Menchaca

    lead OTHER

Principal Investigators

  • Guadalupe Panduro, Ph · Hospital Civil Juan I. Menchaca

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2013-08-31
Completion
2014-03-31

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02363348 on ClinicalTrials.gov